Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis

被引：0
|
作者：
A.S. Koldkjær Sølling
T. Harsløf
B. Langdahl
机构：
[1] Aarhus University Hospital,Department of Endocrinology and Internal Medicine
来源：
Osteoporosis International | 2019年 / 30卷
关键词：
Bone turnover markers; Cathepsin K inhibitor; Odanacatib; Osteoporosis; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：995 / 1002
页数：7
相关论文
共 50 条
  • [21] Odanacatib: an emerging novel treatment alternative for postmenopausal osteoporosis
    Schultz, Thomas C.
    Valenzano, Jonathan P.
    Verzella, Jessica L.
    Umland, Elena M.
    [J]. WOMENS HEALTH, 2015, 11 (06) : 805 - 814
  • [22] Genistein prevents bone loss in early postmenopausal women
    Morabito, N
    Gaudio, A
    Crisafulli, A
    Vergara, C
    Lasco, A
    D'Anna, R
    Corrado, F
    Pizzoleo, MA
    Squadrito, F
    Frisina, N
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S22 - S23
  • [23] Alendronate prevents bone loss in Chinese women with osteoporosis
    Lau, EMC
    Woo, J
    Chan, YH
    Griffith, J
    [J]. BONE, 2000, 27 (05) : 677 - 680
  • [24] Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
    Kang, Taewook
    Park, Si Young
    Lee, Soon Hyuck
    Park, Jong Hoon
    Suh, Seung Woo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (13)
  • [25] Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women
    Chapurlat, Roland D.
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2015, 7 (03) : 103 - 109
  • [26] Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis
    Devareddy, Latha
    Hooshmand, Shirin
    Collins, Julie K.
    Lucas, Edralin A.
    Chai, Sheau C.
    Arjmandi, Bahram H.
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2008, 19 (10): : 694 - 699
  • [27] A Clinician's Perspective on the Use of Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis
    Lewiecki, E. Michael
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2008, 11 (04) : 478 - 484
  • [28] The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study
    Gokosmanoglu, Feyzi
    Varim, Ceyhun
    Atmaca, Aysegul
    Atmaca, Mehmet Hulusi
    Colak, Ramis
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2016, 21
  • [29] Yearly zoledronic acid in postmenopausal osteoporosis - Reply
    Black, Dennis
    Eriksen, Erik
    Sellmeyer, Deborah
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (07): : 714 - 715
  • [30] Zoledronic Acid Acutely Increases Sclerostin Serum Levels in Women With Postmenopausal Osteoporosis
    Catalano, Antonino
    Morabito, Nancy
    Basile, Giorgio
    Brancatelli, Santa
    Cucinotta, Domenico
    Lasco, Antonino
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (05): : 1911 - 1915
12345